Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in Interest ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nuvation Bio (NUVB) Net Cash Flow (2023 - 2025)

Historic Net Cash Flow for Nuvation Bio (NUVB) over the last 3 years, with Q3 2025 value amounting to -$149.0 million.

  • Nuvation Bio's Net Cash Flow fell 414907.33% to -$149.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $67.8 million, marking a year-over-year increase of 97500.4%. This contributed to the annual value of -$7.4 million for FY2024, which is 8737.55% up from last year.
  • Nuvation Bio's Net Cash Flow amounted to -$149.0 million in Q3 2025, which was down 414907.33% from $200.1 million recorded in Q2 2025.
  • Over the past 5 years, Nuvation Bio's Net Cash Flow peaked at $200.1 million during Q2 2025, and registered a low of -$149.0 million during Q3 2025.
  • Its 3-year average for Net Cash Flow is -$238181.8, with a median of -$303000.0 in 2024.
  • Within the past 5 years, the most significant YoY rise in Nuvation Bio's Net Cash Flow was 6614653.47% (2025), while the steepest drop was 414907.33% (2025).
  • Over the past 3 years, Nuvation Bio's Net Cash Flow (Quarter) stood at $18.3 million in 2023, then crashed by 74.96% to $4.6 million in 2024, then plummeted by 3360.72% to -$149.0 million in 2025.
  • Its Net Cash Flow stands at -$149.0 million for Q3 2025, versus $200.1 million for Q2 2025 and $12.1 million for Q1 2025.